MétaCan
Menu
Back to cohort
Record W2939627719 · doi:10.1093/sleep/zsz067.471

0473 Alendronate is Associated With a Significantly Higher Odds of Obstructive Sleep Apnea (OSA): Results from the US FDA Adverse Events Reporting System (FAERS)

2019· article· en· W2939627719 on OpenAlexaff
Madhulika A. Gupta, Branka Vujčić

Bibliographic record

VenueSLEEP · 2019
Typearticle
Languageen
FieldMedicine
TopicBone and Joint Diseases
Canadian institutionsWestern University
FundersNational Taiwan UniversityNational Taiwan University Hospital Yunlin BranchNational Taiwan University Hospital
KeywordsMedicineMedDRAOdds ratioObstructive sleep apneaInternal medicineAdverse Event Reporting SystemAdverse effectBisphosphonateConfidence intervalPolysomnographyOsteoporosisPharmacovigilanceApnea

Abstract

fetched live from OpenAlex

OSA is recognized as a heterogeneous disorder. The literature on the role of medications in OSA pathogenesis has tended to focus on central nervous depressants. We examined the association of Alendronate (a commonly used bisphosphonate that is FDA-approved for osteoporosis and Paget’s disease of the bone) and OSA. Alendronate was among one of the 5 most frequent medications documented as primary suspect (PS) for the adverse effect (AE) of OSA in the FAERS post-marketing individual safety reports (ISR). To our knowledge the association of Alendronate and OSA has not been previously reported. We examined the FAERS database from January 1, 2004-June 30, 2017 (total ISR =9,553,117) and examined ISRs where Alendronate was documented as PS for the AE of OSA. Medical Dictionary for Regulatory Activities (MedDRA) preferred term of ‘Sleep apnoea syndrome’ (MedDRA code 10040979) was used to select ISRs designating OSA as AE. Reporting odds ratios (ROR) with 95% confidence intervals (CI) were calculated to assess disproportionality signals for OSA both when Alendronate (i) was used for FDA-approved indications, and (ii) when used for any indication. Results: Overall there were 626,321 ISR for Alendronate (mean+/-SD age: 61.20+/-11.06 years, age data on 437,493 ISR; 94.3% female, 5.7% male, gender data on 538,566 ISR). When used for FDA-approved indications (OSA-related ISR=625) versus all other medications for the same indications (OSA-related ISR=129), the disproportionality signal for OSA was 6.20 (95% 5.13-7.49), z=18.86, p<0.0001. For Alendronate used for any indication (OSA-related ISR=917) versus all other medications for any indication (OSA-related ISR=10,998) the disproportionality signal for OSA was 3.74 (95% CI 3.50-4.00), z=38.36, p<0.0001. Alendronate was associated with a previously unreported higher odds of OSA both (i) when used for FDA-approved indications, and (ii) when used for any indication. Factors other than the primary FDA indications (that could theoretically affect chest wall function), such as possible direct irritation of portions of the upper airway by Alendronate and its pro-inflammatory actions, may be important. None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.020
Threshold uncertainty score0.719

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.237
Teacher spread0.221 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueSLEEPSame topicBone and Joint DiseasesFrench-language works237,207